Dattatrya Shetti

565 total citations
11 papers, 333 citations indexed

About

Dattatrya Shetti is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Dattatrya Shetti has authored 11 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Dattatrya Shetti's work include Cancer-related molecular mechanisms research (3 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (2 papers). Dattatrya Shetti is often cited by papers focused on Cancer-related molecular mechanisms research (3 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (2 papers). Dattatrya Shetti collaborates with scholars based in China, Czechia and Germany. Dattatrya Shetti's co-authors include Kun Wei, Conghui Fan, Bao Zhang, Bao Zhang, Bae Hoon Lee, Amit Singh Yadav, Anuradha Bulbule, Mahadeo Gorain, Thejus Baby and Gopal C. Kundu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Nanoscale and Molecules.

In The Last Decade

Dattatrya Shetti

11 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dattatrya Shetti China 7 181 91 65 57 51 11 333
Kah Jing Lim United States 6 211 1.2× 97 1.1× 53 0.8× 79 1.4× 47 0.9× 9 376
Paweena Dana Thailand 12 178 1.0× 63 0.7× 55 0.8× 88 1.5× 37 0.7× 20 341
Arul Goel United States 7 237 1.3× 88 1.0× 56 0.9× 87 1.5× 72 1.4× 13 438
S. Neslihan Alpay United States 6 308 1.7× 84 0.9× 71 1.1× 70 1.2× 49 1.0× 7 438
Amanda E. Brinker United States 11 207 1.1× 76 0.8× 43 0.7× 77 1.4× 39 0.8× 15 351
Yunqi Li China 9 152 0.8× 37 0.4× 58 0.9× 58 1.0× 71 1.4× 25 351
Parham Rahmanian Iran 9 137 0.8× 71 0.8× 45 0.7× 42 0.7× 46 0.9× 12 282
Lucyna Matusewicz Poland 6 138 0.8× 120 1.3× 91 1.4× 50 0.9× 56 1.1× 7 307
Farzad Nasri Iran 6 169 0.9× 93 1.0× 64 1.0× 72 1.3× 96 1.9× 13 388

Countries citing papers authored by Dattatrya Shetti

Since Specialization
Citations

This map shows the geographic impact of Dattatrya Shetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dattatrya Shetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dattatrya Shetti more than expected).

Fields of papers citing papers by Dattatrya Shetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dattatrya Shetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dattatrya Shetti. The network helps show where Dattatrya Shetti may publish in the future.

Co-authorship network of co-authors of Dattatrya Shetti

This figure shows the co-authorship network connecting the top 25 collaborators of Dattatrya Shetti. A scholar is included among the top collaborators of Dattatrya Shetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dattatrya Shetti. Dattatrya Shetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Shetti, Dattatrya, et al.. (2024). Emerging role of circulating cell-free RNA as a non-invasive biomarker for hepatocellular carcinoma. Critical Reviews in Oncology/Hematology. 200. 104391–104391. 2 indexed citations
2.
Shetti, Dattatrya, Lenka Červenková, Richard Pálek, et al.. (2024). Small nucleolar RNA expression profiles: A potential prognostic biomarker for non-viral Hepatocellular carcinoma. Non-coding RNA Research. 9(4). 1133–1139. 2 indexed citations
3.
Polívka, Jiří, et al.. (2023). Preoperative Plasma miRNA Levels Predict Prognosis in Early-stage Malignant Melanoma. Anticancer Research. 43(2). 695–706. 5 indexed citations
4.
Pešta, Martin, et al.. (2022). Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer. Diagnostics. 12(8). 1799–1799. 16 indexed citations
5.
Polívka, Jiří, et al.. (2022). Oncogenic Fusions in Gliomas: An Institutional Experience. Anticancer Research. 42(4). 1933–1939. 5 indexed citations
6.
Yadav, Amit Singh, Mahadeo Gorain, Anuradha Bulbule, et al.. (2020). RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer. Nanoscale. 12(19). 10664–10684. 78 indexed citations
7.
Shetti, Dattatrya, et al.. (2019). Erianin Inhibits Proliferation and Induces Apoptosis of HaCaT Cells via ROS-Mediated JNK/c-Jun and AKT/mTOR Signaling Pathways. Molecules. 24(15). 2727–2727. 43 indexed citations
10.
Zhang, Bao, Dattatrya Shetti, Conghui Fan, & Kun Wei. (2019). miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3. Biological Research. 52(1). 38–38. 63 indexed citations
11.
Fan, Conghui, et al.. (2019). Resveratrol loaded oxidized mesoporous carbon nanoparticles: A promising tool to treat triple negative breast cancer. Biochemical and Biophysical Research Communications. 519(2). 378–384. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026